SCHEMBL7080435

SCHEMBL7080435

N=C(N)c1c(O)c2ccccc2n(CC2CCOC2)c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 3/20 0.48
ERCC5 P28715 1/20 0.48
GSK3B P49841 1/20 0.45
CNR2 P34972 2/20 0.42
CNR1 P21554 1/20 0.42
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
HTR3A P46098 1/20 0.41
HTR3D Q70Z44 1/20 0.41
HTR3C Q8WXA8 1/20 0.41
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
KDM4E B2RXH2 3/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
TLR7 Q9NYK1 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11372077 0.73 GSK3B (0.60) FEN1GSK3BNPC1KMT2AMEN1
SCHEMBL6737897 0.72 CNR2 (0.46) FEN1ERCC5CNR2CNR1KDM4E
SCHEMBL6233670 0.70 MAPK1 (0.63) FEN1ERCC5GSK3BCNR2CNR1
SCHEMBL6208525 0.70 MEN1 (0.60) NPC1GAAKMT2AMEN1KDM4E
SCHEMBL11389635 0.68 KDM4E (0.76) GSK3BKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL7073582 0.68 KDM4E (0.49) GAAKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL13011130 0.68 CNR2 (0.55) FEN1ERCC5CNR2CNR1KDM4E
SCHEMBL13011633 0.67 CNR2 (0.50) CNR2CNR1NPC1
SCHEMBL38660055 0.66 GSK3B (0.71) GSK3BKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL20864215 0.65 FEN1 (1.00) FEN1ERCC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059356-A2 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2003-07-24 WO claimed
WO-2003059356-A2 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2003-07-24 WO disclosed